|
AP10463B-ev
|
Abcepta, Inc.
|
IL-12B [C-term] [RB28444], Rabbit Polyclonal Antibody
|
Human
|
WB, FC, IHC-P
|
|
|
AP10463B
|
Abcepta, Inc.
|
IL-12B [C-term] [RB28444], Rabbit Polyclonal Antibody
|
Human
|
WB, FC, IHC-P
|
|
|
PH304151
|
OriGene Technologies
|
Bone marrow stromal cell antigen 1 (BST1) (NM_004334) Human Mass Spec Standard
|
|
|
|
|
PH313683
|
OriGene Technologies
|
Cell adhesion molecule 4 (CADM4) (NM_145296) Human Mass Spec Standard
|
|
|
|
|
PH309047
|
OriGene Technologies
|
Host cell factor C1 regulator 1 (HCFC1R1) (NM_017885) Human Mass Spec Standard
|
|
|
|
|
PH300224
|
OriGene Technologies
|
Malignant T cell amplified sequence 1 (MCTS1) (NM_014060) Human Mass Spec Standard
|
|
|
|
|
HY-123099-25mg
|
MedChemexpress LLC
|
MS-1020 [CAS 1255516-86-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-140383-100mg
|
MedChemexpress LLC
|
Ms-PEG2-C2-Boc [CAS 1312309-62-8]
|
|
Cancer-programmed cell death
|
|
|
HY-140383-250mg
|
MedChemexpress LLC
|
Ms-PEG2-C2-Boc [CAS 1312309-62-8]
|
|
Cancer-programmed cell death
|
|
|
HY-140383-50mg
|
MedChemexpress LLC
|
Ms-PEG2-C2-Boc [CAS 1312309-62-8]
|
|
Cancer-programmed cell death
|
|
|
HY-140382-1g
|
MedChemexpress LLC
|
Ms-PEG2-Ms [CAS 34604-52-9]
|
|
Cancer-programmed cell death
|
|
|
HY-140382-5g
|
MedChemexpress LLC
|
Ms-PEG2-Ms [CAS 34604-52-9]
|
|
Cancer-programmed cell death
|
|
|
HY-42774-100mg
|
MedChemexpress LLC
|
Ms-PEG4-Ms [CAS 55400-73-2]
|
|
Cancer-programmed cell death
|
|
|
HY-42774-500mg
|
MedChemexpress LLC
|
Ms-PEG4-Ms [CAS 55400-73-2]
|
|
Cancer-programmed cell death
|
|
|
HY-W096074-10mg
|
MedChemexpress LLC
|
MS-PEG4-THP [CAS 145927-73-7]
|
|
Cancer-programmed cell death
|
|
|
HY-W096074-100mg
|
MedChemexpress LLC
|
MS-PEG4-THP [CAS 145927-73-7]
|
|
Cancer-programmed cell death
|
|
|
HY-W096074-25mg
|
MedChemexpress LLC
|
MS-PEG4-THP [CAS 145927-73-7]
|
|
Cancer-programmed cell death
|
|
|
HY-W096074-50mg
|
MedChemexpress LLC
|
MS-PEG4-THP [CAS 145927-73-7]
|
|
Cancer-programmed cell death
|
|
|
HY-P1052A-1mg
|
MedChemexpress LLC
|
Myelin Basic Protein(87-99) (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1052A-10mg
|
MedChemexpress LLC
|
Myelin Basic Protein(87-99) (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1052A-5mg
|
MedChemexpress LLC
|
Myelin Basic Protein(87-99) (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-130584-100mg
|
MedChemexpress LLC
|
Propargyl-PEG2-Ms [CAS 943726-01-0]
|
|
Cancer-programmed cell death
|
|
|
HY-130584-250mg
|
MedChemexpress LLC
|
Propargyl-PEG2-Ms [CAS 943726-01-0]
|
|
Cancer-programmed cell death
|
|
|
HY-130584-50mg
|
MedChemexpress LLC
|
Propargyl-PEG2-Ms [CAS 943726-01-0]
|
|
Cancer-programmed cell death
|
|
|
HY-140046-100mg
|
MedChemexpress LLC
|
Propargyl-PEG5-Ms [CAS 1036204-62-2]
|
|
Cancer-programmed cell death
|
|
